The role of magnetic resonance imaging in the early diagnosis of chronic lymphocytic inflammation (CLIPPERS syndrome)

Cover Page

Cite item

Full Text

Abstract

Background: Chronic lymphocytic inflammation with perivascular contrast enhancement in the pons responsive to steroids (CLIPPERS) is a rare and relatively new pathology and magnetic resonance imaging (MRI) is highly important in its diagnosis.

Clinical case description: The analysis of the MRI results revealed typical changes characteristic of CLIPPERS, such as contrast-positive small-point and curvilinear lesions of the pons, medulla oblongata and midbrain, as well as of the cerebral peduncles and cerebellum. In addition to the changes we described, according to the literature, lesions of the white matter of the large hemispheres and thalami may also be observed in the syndrome of chronic lymphocytic inflammation.

Conclusion: MRI not only enables one to achieve high-quality neuroimaging of CLIPPERS, but also allows avoiding invasive, traumatic diagnostic methods.

About the authors

Lyubov E. Fomina

National Medical Research Center for Children's Health

Author for correspondence.
Email: love.fomina@mail.ru
ORCID iD: 0000-0002-3838-3284
SPIN-code: 1298-8350

researcher, laboratory of radiation and instrumental diagnostics

Russian Federation, 2 b. 1, Lomonosovsky prospect, Moscow, 119991

Irina N. Kieva

G.N. Speransky Children's City Clinical Hospital № 9

Email: miamodiaz@gmail.com
ORCID iD: 0000-0002-4060-5966
SPIN-code: 2279-9141

radiologist

Russian Federation, Moscow

Anatoly V. Anikin

National Medical Research Center for Children's Health

Email: anikacor@gmail.com
ORCID iD: 0000-0003-0362-6511
SPIN-code: 7592-1352

MD, PhD

Russian Federation, Moscow

Nikolay V. Nudnov

Russian Scientific Center of Roentgenoradiology

Email: nudnov@rncrr.ru
ORCID iD: 0000-0001-5994-0468
SPIN-code: 3018-2527

MD, PhD

Russian Federation, Moscow

Luizat M. Abdullaeva

National Medical Research Center for Children's Health

Email: instorm@inbox.ru
ORCID iD: 0000-0003-1574-2050

neurologist

Russian Federation, Moscow

References

  1. Pittock SJ, Debruyne J, Krecke KN, et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2010;133(9):2626–2634. doi: 10.1093/brain/awq164
  2. Simon NG, Parrat JD, Barnett MH, et al. Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). J Neurol Neurosurg Psychiatry. 2012;83(1):15–22. doi: 10.1136/jnnp-2011-301054
  3. Nemani T, Udwadia-Hegde A, Keni Karnavat P, et al. CLIPPERS spectrum disorder: A rare pediatric neuroinflammatory condition. Child Neurol Open. 2019;(6):2329048X19831096. doi: 10.1177/2329048X19831096
  4. Dudesek A, Rimmele F, Tesar S, et al. CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders. Clin Exp Immunol. 2014;175(3): 385–396. doi: 10.1111/cei.12204
  5. Rauschenbach L, Kebir S, Radbruch A, et al. Challenging implications of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome with an atypical presentation: Report of two cases. World Neurosurg. 2020;(143):507–512.e1. doi: 10.1016/j.wneu.2020.07.123
  6. Kamişli Ö, Tecellioğlu M, Erbay MF, et al. Two new cases and literature review of clippers syndrome with long-term follow-up. Noro Psikiyatr Ars. 2020;57(2):160–164. doi: 10.5152/npa.2017.22732
  7. Kerrn-Jespersen BM, Lindelof M, Illes Z, et al. CLIPPERS among patients diagnosed with non-specific CNS neuroinflammatory diseases. J Neurol Sci. 2014;343(1-2):224–227. doi: 10.1016/j.jns.2014.06.002
  8. Tobin WO, Guo Y, Krecke KN, et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017; 140(9):2415–2425. doi: 10.1093/brain/awx200
  9. Сиверцева С.А., Сиверцев М.Ю., Бажухин Д.В., и др. Синдром CLIPPERS (обзор литературы и собственное наблюдение) // Журнал неврологии и психиатрии им. C.C. Корсакова. 2017. Т. 117, № 10-2. С. 24-34. [Sivertseva SA, Sivertsev MY, Bazhukhin DV, et al. CLIPPERS syndrome (literature review and own observation). J Neurology Psychiatry named after C.C. Korsakov. 2017;117(10-2):24–34. (In Russ).] doi: 10.17116/jnevro201711710224-34
  10. Buttmann M, Metz I, Brecht I, et al. Atypical chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS), primary angiitis of the CNS mimicking CLIPPERS or overlap syndrome? A case report. J Neurol Sci. 2013;324(1-2):183–186. doi: 10.1016/j.jns.2012.10.017
  11. Cordano C, López GY, Bollen AW, Nourbakhsh B. Occipital headache in chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Headache. 2018;58(3):458–459. doi: 10.1111/head.13232
  12. Taieb G, Allou T, Labauge P. Therapeutic approaches in CLIPPERS. Curr Treat Options Neurol. 2017;19(5):17. doi: 10.1007/s11940-017-0455-4
  13. Taieb G, Duflos C, Renard D, et al. Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients. Arch Neurol. 2012;69(7):847–855. doi: 10.1001/archneurol.2012.122
  14. Picarelli H, Yamaki VN, Casal YR, et al. CLIPPERS with exclusive extra pontine involvement. Neurol Neuroimmunol Neuroinflamm. 2021;8(3):e989. doi: 10.1212/NXI.0000000000000989
  15. Ambia AR, Al Zahrani N, Almakadma AH, et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: an acute presentation. Cureus. 2022;14(1):e21382. doi: 10.7759/cureus.21382
  16. Dang YL, Kok HK, McKelvie PA, et al. Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) and its association with Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis: A case report. BMC Neurol. 2021;21(1):80. doi: 10.1186/s12883-021-02110-1

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Primary MRI of the brain in the axial plane of March 12, 2020 without intravenous contrast enhancement (a, в — T2-weighted image; б, г — FLAIR): there are multiple bilateral punctate and curvilinear small foci of the altered MR signal, including confluent foci, located in the pons, cerebellar peduncles and the white matter of the brain hemispheres and cerebellum (arrows).

Download (1MB)
3. Fig. 2. Follow-up (after 5 days of pulse therapy) MRI of the brain in the axial plane of August 16, 2021 with intravenous contrast enhancement (a, в — T2-weighted image; б, г — FLAIR; д, е — T1-weighted image before and after contrast enhancement respectively): compared with the MRI data of March 12, 2020, small foci of the altered MR signal with the same localization, structure and size remain (arrows). A short-term pulse therapy course doesn’t result in strong contrast enhancement (arrows).

Download (1MB)
4. Fig. 3. MRI of the brain in the axial plane of January 10, 2022 with intravenous contrast enhancement (a, в — T2-weighted image; б, г — T1-weighted image after contrast enhancement): compared with the MRI data of August 16, 2021, small foci of the altered MR signal with the same localization, structure and size remain (arrows). Strong positive contrast enhancement is visualized (arrows).

Download (1MB)
5. Fig. 4. MRI of the brain in the axial plane of March 25, 2022 with intravenous contrast enhancement in the acute stage of CLIPPERS (a, в — T2-weighted image; б, г — T1-weighted image after contrast enhancement): compared with the MRI data of August 16, 2021, a negative trend is observed namely an increase in the size and number of foci with strong contrast enhancement (arrows).

Download (1MB)
6. Fig. 5. MRI of the brain in the axial plane of June 15, 2022 with intravenous contrast enhancement after a course of pulse therapy and maintenance therapy with corticosteroids for three months (a, в, д — T2-weighted image; б, г, е — T1-weighted image after contrast enhancement): compared with the MRI data of March 25, 2022 there is a regression of focal changes in the subtentorial structures (arrows). Absence of pathological contrast enhancement.

Download (1MB)
7. Fig. 6. MRI of the brain in the axial plane of October 27, 2022 with intravenous contrast enhancement after a maintenance therapy with corticosteroids for seven months (a, б — T1-weighted image before and after contrast enhancement respectively; в, д — T2-weighted image; г, е — FLAIR): compared with the MRI data of June 15, 2022 no new focal changes have appeared. Absence of pathological contrast enhancement. However there are changes of the MR signal in the pons (white arrows) and changes of the white matter of the brain hemispheres with secondary dilatation of liquor spaces (red arrows) specific to pseudoatrophy during the treatment with steroids.

Download (1MB)
8. Fig. 7. Fragments of MRI studies obtained in the order they were performed that allow one to clearly assess the dynamics of changes.

Download (1MB)

Copyright (c) 2023 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies